Experienced in Cellulitis

Dr. James Whalen

Dermatology
Central Connecticut Dermatology PLLC
1 Willowbrook Rd Ste 2, 
Cromwell, CT 
Experienced in Cellulitis
Central Connecticut Dermatology PLLC
1 Willowbrook Rd Ste 2, 
Cromwell, CT 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

James Whalen is a Dermatologist in Cromwell, Connecticut. Dr. Whalen is rated as an Experienced provider by MediFind in the treatment of Cellulitis. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Head and Neck Squamous Cell Carcinoma (HNSCC), and Bowen's Disease.

His clinical research consists of co-authoring 4 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in CT
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 3 Less Insurance Carriers -

Locations

Central Connecticut Dermatology PLLC
1 Willowbrook Rd Ste 2, Cromwell, CT 06416
Other Locations
Office
1 Northwestern Dr Ste 301, Bloomfield, CT 06002

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
A 12-Week, Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy Safety and Tolerability of Gemcabene in Subjects With Severe Hypertriglyceridemia (INDIGO-1)
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
12 Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From A Major Depressive Disorder (MDD) Having Had- Within the Current Episode- An Inadequate Response to at Least One Medication Included in GeneSight Psychotropic
12 Week, Randomized, Double-Blind, Controlled Evaluation Followed by an Open Label 12-Week Follow-up Period of the Impact of GeneSight Psychotropic on Response to Psychotropic Treatment in Outpatients Suffering From A Major Depressive Disorder (MDD) Having Had- Within the Current Episode- An Inadequate Response to at Least One Medication Included in GeneSight Psychotropic
Enrollment Status: Completed
Publish Date: January 14, 2020
Intervention Type: Genetic
Study Phase: Not Applicable
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
A Study of Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute TReaTment of MigrAiNe: A Randomized, Double-blind, Placebo-controlled Parallel Group Study (SPARTAN)
Enrollment Status: Completed
Publish Date: September 23, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

4 Total Publications

A Novel Approach to the Use of 2-Octyl Cyanoacrylate to Reduce Postoperative Hemorrhage After Mohs Micrographic Surgery.
A Novel Approach to the Use of 2-Octyl Cyanoacrylate to Reduce Postoperative Hemorrhage After Mohs Micrographic Surgery.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
Published: November 09, 2020
Similar Doctors
Experienced in Cellulitis
Dr. Reid A. Waldman
Dermatology
Experienced in Cellulitis
Dr. Reid A. Waldman
Dermatology

Dermatology Associates Of Glastonbury LLC

210 New London Tpke, 
Glastonbury, CT 
 (8.5 miles away)
860-633-1543
Languages Spoken:
English
See accepted insurances

Reid Waldman is a Dermatologist in Glastonbury, Connecticut. Dr. Waldman is rated as a Distinguished provider by MediFind in the treatment of Cellulitis. His top areas of expertise are Pompholyx Eczema, Squamous Cell Skin Carcinoma, Neurocutaneous Melanosis, and Giant Congenital Melanocytic Nevus.

Experienced in Cellulitis
Dr. Sonal Muzumdar
Dermatology
Experienced in Cellulitis
Dr. Sonal Muzumdar
Dermatology

Office

399 Farmington Ave Ste 260, 
Farmington, CT 
 (12.5 miles away)
860-676-7000
Languages Spoken:
English
See accepted insurances

Sonal Muzumdar is a Dermatologist in Farmington, Connecticut. Dr. Muzumdar is rated as an Advanced provider by MediFind in the treatment of Cellulitis. Her top areas of expertise are Parapsoriasis, Squamous Cell Skin Carcinoma, Basal Cell Skin Cancer, and Cellulitis.

Experienced in Cellulitis
Dr. Jonathan Leventhal
Dermatology
Experienced in Cellulitis
Dr. Jonathan Leventhal
Dermatology

Yale Dermatology Associates PC

2 Church St S Ste 305, 
New Haven, CT 
 (24.9 miles away)
203-785-4445
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Jonathan Leventhal is a Dermatologist in New Haven, Connecticut. Dr. Leventhal is rated as a Distinguished provider by MediFind in the treatment of Cellulitis. His top areas of expertise are Bullous Pemphigoid, Melanoma, Localized Scleroderma, and Punctate Porokeratosis.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Whalen's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile